Blonanserin 4mg Tablet PCD Franchise in Mumbai

Antipsychotic Medicine Supplier in Delhi

Schizophrenia & Psychiatry Tablet Distributor in Chennai

Mental Health Pharma Franchise in Pune

Blonanserin 4mg Stockist in Kolkata
Psychiatric Medicine Export & Manufacturing in Hyderabad

Home/Products /blonanserin-4-mg-tablet

Blorin 4 Tablet

Composition : Blonanserin (4mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*1*10

Price : ₹1/-

Blorin 4 Tablet contains Blonanserin 4mg, an atypical antipsychotic used for the management of schizophrenia and related psychotic disorders. It works by modulating dopamine and serotonin receptors, helping to stabilize mood, reduce hallucinations, and control delusions.

Belonging to the psychiatry and neurology segment, Blorin 4 Tablet is widely prescribed in hospitals, psychiatric clinics, and mental health centers. Its efficacy in symptom management makes it a preferred choice among psychiatrists and neurologists.

Blonanserin is known for its improved safety profile and tolerability, supporting long-term adherence to therapy. This makes it a reliable option for patients requiring continuous antipsychotic management.

For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Blorin 4 Tablet offers a profitable B2B opportunity. Its essential use in psychiatric care ensures recurring demand and strong market presence across India.


Read More

About the Product

Blorin 4 Tablet contains Blonanserin 4mg, an atypical antipsychotic used for the management of schizophrenia and related psychotic disorders. It works by modulating dopamine and serotonin receptors, helping to stabilize mood, reduce hallucinations, and control delusions.

Belonging to the psychiatry and neurology segment, Blorin 4 Tablet is widely prescribed in hospitals, psychiatric clinics, and mental health centers. Its efficacy in symptom management makes it a preferred choice among psychiatrists and neurologists.

Blonanserin is known for its improved safety profile and tolerability, supporting long-term adherence to therapy. This makes it a reliable option for patients requiring continuous antipsychotic management.

For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Blorin 4 Tablet offers a profitable B2B opportunity. Its essential use in psychiatric care ensures recurring demand and strong market presence across India.


Common side effects include drowsiness, dizziness, weight gain, dry mouth, and mild gastrointestinal discomfort. Rare but serious effects may include severe movement disorders (extrapyramidal symptoms), neuroleptic malignant syndrome, or cardiac arrhythmias. Seek medical attention if severe stiffness, high fever, or irregular heartbeat occurs.

Blorin 4 Tablet is indicated for the treatment of schizophrenia and related psychotic disorders. It helps reduce hallucinations, delusions, agitation, and other behavioral symptoms, supporting better daily functioning.

Take Blorin 4 Tablet exactly as prescribed. Do not discontinue abruptly, as this may worsen symptoms. Inform your doctor if you have a history of heart disease, seizures, diabetes, or low blood pressure. Regular monitoring of side effects and therapeutic response is recommended.

Store Blorin 4 Tablet in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation